How are 2 NZX healthcare stocks faring amid the pandemic?

Highlights

• The healthcare sector saw major changes and action in the pandemic-stricken world.
• Management additions done by Oceania Healthcare.
• Ryman Healthcare’s Chief Development Officer Jeremy Moore went through the role change.

The healthcare industry is one that has seen the most action in the past one and a half years due to the pandemic.

While front liners across the world risked their lives to provide appropriate care and support to the people ailing from COVID-19, there were a number of reductions in other kinds of medical requirements, elective surgeries accidents and patients being treated for several other reasons.

While the industry overworked, the silver lining is that it has majorly done well in different parts of the world.

Let’s talk about 2 such NZX-listed healthcare stocks.

Image source: © 2021 Kalkine Media New Zealand Lt; data source: EODHD/Others

Oceania Healthcare Limited (NZX:OCA)

Offering retirement homes and aged care facilities, this company functions in over 40 locations in the country.

Recently, the Company welcomed Peter Dufaur and Rob Hamilton in the roles of non-executive Directors. They bring sound experience and skill to the Company, which will prove to be immensely beneficial.

The 52-week high-low for the Company was recorded at NZ$1.60-NZ$1.01 while the market cap was recorded to be NZ$1,06,56,16000.

On 24 September 2021, at the time of writing, the stock was trading at NZ$1.530, up by 0.66%.

Read more: Are these 10 best healthcare companies on the NZX?

Ryman Healthcare Limited (NZX: RYM)

The Company operates through different parts of New Zealand and Australia with over 36 different locations. In a recent announcement by the Company, Richard Umbers has been appointed new CEO for the group. He shall take up the role from October 2021.

Besides this, Jeremy Moore, the Chief Development Officer for the company, shall take on a part-time role as the land acquisition manager for New Zealand. The 52-week High-low recorded for the Company was NZ$16.02-NZ$12.46 while the market cap was NZ$7,65,00,00,000.

On 24 September 2021, at the time of writing, the stock was trading at NZ$15.2, up by 0.46%.

Don’t miss: Are these 5 NZX healthcare stocks flourishing amid COVID-19?

Bottom Line

New Zealand has a superior quality health care system and has various companies functioning under it. The sector has often caught investors’ attention due to its boom amid the pandemic.